Communiqués FendX Technologies Inc.

Actions

FNDX

CA3144602057

Services et équipements environnementaux

Temps Différé Canadian Securities Exchange 15:59:43 11/09/2026			Varia. 5j.	Varia. 1 janv.
0,1900 ^CAD	+5,56%		-5,00%	-50,00%

29/08	FendX Technologies Inc. publie ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2026	CI
28/05	FendX Technologies Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

07/07	FendX Engages Technical Development and Design Expertise to Advance Its Surface Contamination Detection App Program	NE
30/04	FendX Engages Innovotech for Regulatory Pathway Assessment of Its Coated Foley Catheter Program	NE
15/04	FendX Engages Galenvs for Pilot Scale-Up Manufacturing of Its Liquid Surface Coating	NE
31/03	FendX Provides Corporate Update	NE
22/01	FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents	NE
01/01	FendX Provides Corporate Update	NE
02/12	FendX Provides Corporate Update	NE
22/11	FendX Provides Corporate Update	NE
18/11	FendX and Aquaox Sign MOU to Pursue Innovation in Sustainable Pathogen Elimination	NE
22/10/25	FendX Files Provisional Patent for Novel Antimicrobial Nanoparticle Liquid Coating	NE
26/08/25	FendX Advances Medical Catheter Coating Innovation: Provisional Patent Filed	NE
20/08/25	AI-Powered Pathogen Detection App: Provisional Patent Filed by FendX CEO	NE
14/08/25	CSE Bulletin: Consolidation - FendX Technologies Inc. (FNDX)	NE
13/08/25	FendX Provides Corporate Update	NE
19/07/25	FendX Provides Corporate Update	NE
08/07/25	REPELWRAP(TM) Film Demonstrated Continued Performance Success in Second Real-World Testing and FendX Provides Corporate Update	NE
11/06/25	FendX Engages Branding Expert to Support Branding and Marketing for Its Planned Eco-Friendly Sponge Products	NE
06/05/25	FendX Announces Share Issuance Pursuant to IP License Agreement	NE
24/04/25	FendX Enters into an Exclusive Supply Agreement and Signs Exclusive IP License Agreement with Scott Smith and US BioSolutions	NE
17/04/25	FendX Provides Corporate Update	NE
09/04/25	FendX Discusses CDC Recent Reports on the Rise of Antimicrobial Resistance	NE
07/04/25	FendX Provides Shareholder Update	NE
22/03/25	FendX Announces Grant of Stock Options and RSUs	NE
14/03/25	FendX Technologies Announces Fully Subscribed Closing of Non-Brokered Private Placement	NE
13/03/25	FendX Shares Early Results from Real-World Testing of REPELWRAP Film and Provides Corporate Update	AQ